Lumiracoxib is a COX-2 selective inhibitor nonsteroidal anti-inflammatory drug.
via PubMed
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 408580996 | IUPAC_name = {2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid | image = Lumiracoxib.svg | image_class = skin-invert-image | width = 180px
| tradename = Prexige | Drugs.com = | pregnancy_AU = C | legal_status = Rx-only, withdrawn (Australia, New Zealand, Canada, UK, Germany, Austria, Belgium, Cyprus, Brazil) | routes_of_administration = Oral
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).